149 related articles for article (PubMed ID: 17506064)
1. Hydroxyurea therapy for management of secondary erythrocytosis in cyanotic congenital heart disease.
Reiss UM; Bensimhon P; Zimmerman SA; Ware RE
Am J Hematol; 2007 Aug; 82(8):740-3. PubMed ID: 17506064
[TBL] [Abstract][Full Text] [Related]
2. Blood is thicker than water: the management of hyperviscosity in adults with cyanotic heart disease.
DeFilippis AP; Law K; Curtin S; Eckman JR
Cardiol Rev; 2007; 15(1):31-4. PubMed ID: 17172881
[TBL] [Abstract][Full Text] [Related]
3. Iron deficiency in a patient with extreme erythrocytosis due to cyanotic congenital heart disease.
Braun SL; Eicken A; Kaemmerer H
Int J Cardiol; 2007 Mar; 116(2):e74-5. PubMed ID: 17097163
[TBL] [Abstract][Full Text] [Related]
4. A clinico-hematological study of iron deficiency anemia and its correlation with hyperviscosity symptoms in cyanotic congenital heart disease.
Gaiha M; Sethi HP; Sudha R; Arora R; Acharya NR
Indian Heart J; 1993; 45(1):53-5. PubMed ID: 8365742
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of blood rheology in patients with cyanotic congenital heart disease using a microchannel array flow analyzer.
Katayama Y; Horigome H; Murakami T; Takahashi-Igari M; Miyata D; Tanaka K
Clin Hemorheol Microcirc; 2006; 35(4):499-508. PubMed ID: 17148849
[TBL] [Abstract][Full Text] [Related]
6. Cyanotic congenital heart disease (CCHD) with symptomatic erythrocytosis.
Rose SS; Shah AA; Hoover DR; Saidi P
J Gen Intern Med; 2007 Dec; 22(12):1775-7. PubMed ID: 17917783
[TBL] [Abstract][Full Text] [Related]
7. [Chemotherapy against polycythemia due to a cyanotic congenital heart disease in adults. One case report].
Boussaada R; Békir S; Ben Romdhane N; Mechmèche R
Tunis Med; 2007 May; 85(5):437-40. PubMed ID: 17657936
[TBL] [Abstract][Full Text] [Related]
8. [Long-term hematological management of cyanotic congenital heart diseases].
Cornu P
Arch Mal Coeur Vaiss; 1994 Nov; 87(11):1413-20. PubMed ID: 7771887
[TBL] [Abstract][Full Text] [Related]
9. Soluble P-selectin and thrombomodulin-protein C-Protein S pathway in cyanotic congenital heart disease with secondary erythrocytosis.
Horigome H; Murakami T; Isobe T; Nagasawa T; Matsui A
Thromb Res; 2003; 112(4):223-7. PubMed ID: 14987915
[TBL] [Abstract][Full Text] [Related]
10. Fetal haemoglobin variations following hydroxyurea treatment in patients with cyanotic congenital heart disease.
Triadou P; Maier-Redelsperger M; Krishnamoorty R; Deschamps A; Casadevall N; Dunda O; Ducrocq R; Elion J; Girot R; Labie D
Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):367-72. PubMed ID: 7534399
[TBL] [Abstract][Full Text] [Related]
11. Cyanotic congenital heart disease (CCHD): focus on hypoxemia, secondary erythrocytosis, and coagulation alterations.
Zabala LM; Guzzetta NA
Paediatr Anaesth; 2015 Oct; 25(10):981-9. PubMed ID: 26184479
[TBL] [Abstract][Full Text] [Related]
12. Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease.
Broberg CS; Bax BE; Okonko DO; Rampling MW; Bayne S; Harries C; Davidson SJ; Uebing A; Khan AA; Thein S; Gibbs JS; Burman J; Gatzoulis MA
J Am Coll Cardiol; 2006 Jul; 48(2):356-65. PubMed ID: 16843187
[TBL] [Abstract][Full Text] [Related]
13. Headache and papilledema in an adult with cyanotic congenital heart disease: the importance of fundoscopic evaluation rather than phlebotomy.
Loomba RS; Leavitt JA; Cetta F
Congenit Heart Dis; 2012; 7(3):E14-7. PubMed ID: 22070674
[TBL] [Abstract][Full Text] [Related]
14. Risk of stroke in adults with cyanotic congenital heart disease.
Perloff JK; Marelli AJ; Miner PD
Circulation; 1993 Jun; 87(6):1954-9. PubMed ID: 8504509
[TBL] [Abstract][Full Text] [Related]
15. Transient glomerulonephropathy associated with primary erythrocytosis in a dog.
Page RL; Stiff ME; McEntee MC; Walter LG
J Am Vet Med Assoc; 1990 Feb; 196(4):620-2. PubMed ID: 2303386
[TBL] [Abstract][Full Text] [Related]
16. Overproduction of platelet microparticles in cyanotic congenital heart disease with polycythemia.
Horigome H; Hiramatsu Y; Shigeta O; Nagasawa T; Matsui A
J Am Coll Cardiol; 2002 Mar; 39(6):1072-7. PubMed ID: 11897453
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of canine primary polycythemia and management with hydroxyurea.
Peterson ME; Randolph JF
J Am Vet Med Assoc; 1982 Feb; 180(4):415-8. PubMed ID: 7061327
[TBL] [Abstract][Full Text] [Related]
18. Hydroxyurea for treatment of polycythemia secondary to right-to-left shunting patent ductus arteriosus in 4 dogs.
Moore KW; Stepien RL
J Vet Intern Med; 2001; 15(4):418-21. PubMed ID: 11467603
[TBL] [Abstract][Full Text] [Related]
19. Chronic hypoxaemia and decompensated erythrocytosis in cyanotic congenital heart disease.
Rosove MH; Perloff JK; Hocking WG; Child JS; Canobbio MM; Skorton DJ
Lancet; 1986 Aug; 2(8502):313-5. PubMed ID: 2874330
[TBL] [Abstract][Full Text] [Related]
20. Cerebrovascular accidents in infants and children with congenital cyanotic heart disease.
Amitai Y; Blieden L; Shemtov A; Neufeld H
Isr J Med Sci; 1984 Dec; 20(12):1143-5. PubMed ID: 6519944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
